- Home
- TNGX vs FSBC Comparison
TNGX vs FSBC Comparison
Compare TNGX & FSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- FSBC
- Stock Information
- Founded
- TNGX 2014
- FSBC 2002
- Country
- TNGX United States
- FSBC United States
- Employees
- TNGX N/A
- FSBC N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- FSBC Banks
- Sector
- TNGX Health Care
- FSBC Finance
- Exchange
- TNGX Nasdaq
- FSBC Nasdaq
- Market Cap
- TNGX 723.2M
- FSBC 628.9M
- IPO Year
- TNGX N/A
- FSBC 2021
- Fundamental
- Price
- TNGX $6.90
- FSBC $32.61
- Analyst Decision
- TNGX Strong Buy
- FSBC Buy
- Analyst Count
- TNGX 6
- FSBC 5
- Target Price
- TNGX $10.00
- FSBC $34.80
- AVG Volume (30 Days)
- TNGX 1.9M
- FSBC 36.3K
- Earning Date
- TNGX 08-05-2025
- FSBC 07-23-2025
- Dividend Yield
- TNGX N/A
- FSBC 2.56%
- EPS Growth
- TNGX N/A
- FSBC 2.40
- EPS
- TNGX N/A
- FSBC 2.44
- Revenue
- TNGX $24,296,000.00
- FSBC $132,133,000.00
- Revenue This Year
- TNGX N/A
- FSBC $33.14
- Revenue Next Year
- TNGX N/A
- FSBC $15.40
- P/E Ratio
- TNGX N/A
- FSBC $13.37
- Revenue Growth
- TNGX N/A
- FSBC 18.01
- 52 Week Low
- TNGX $1.03
- FSBC $22.22
- 52 Week High
- TNGX $12.02
- FSBC $35.13
- Technical
- Relative Strength Index (RSI)
- TNGX 56.63
- FSBC 66.42
- Support Level
- TNGX $6.60
- FSBC $30.45
- Resistance Level
- TNGX $7.42
- FSBC $31.63
- Average True Range (ATR)
- TNGX 0.47
- FSBC 1.10
- MACD
- TNGX -0.04
- FSBC 0.14
- Stochastic Oscillator
- TNGX 57.20
- FSBC 90.27
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About FSBC Five Star Bancorp
Five Star Bancorp is a bank holding company through its subsidiary it operates in California state-chartered non-member bank. The Company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment; Banking.